Summary
The U.S. Embassy in Kigali has advised its staff to work remotely in response to the ongoing Marburg hemorrhagic fever outbreak in Rwanda. This recommendation comes as the country grapples with rising case numbers and fatalities linked to the virus, which is believed to spread through close contact with infected individuals.
As of early October 2024, the Marburg outbreak has resulted in at least 12 deaths and dozens of confirmed cases, primarily affecting healthcare workers across multiple districts. The Rwandan government has implemented strict measures to control the spread, including isolating patients and their contacts, suspending school and hospital visits, and limiting funeral attendance for victims. The embassy’s directive reflects heightened concerns over staff safety amid the outbreak, as health authorities continue to investigate its source and work on deploying a vaccine under trial.
Rwanda will deploy Marburg vaccine under trial as death toll rises to 12
Oct. 6 / Abc News / Highlights the initiation of a vaccine study in Rwanda, providing crucial details about the outbreak's impact and response measures, while emphasizing the urgency of addressing the Marburg virus threat. “ KIGALI, Rwanda -- Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever , officials said Sunday, as the East African...
Rwanda's Marburg fever deaths rise to 11 as its source is still being investigated
Oct. 3 / Abc News / Focuses on the rising death toll and ongoing investigations into the outbreak's source, effectively conveying the gravity of the situation and the need for public caution, but lacks the latest vaccine developments. “ KIGALI, Rwanda -- Marburg hemorrhagic fever has killed 11 people in Rwanda, health authorities said, as the East African country continues to investigate the...